BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17107951)

  • 1. Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development.
    Stack CM; Lowther J; Cunningham E; Donnelly S; Gardiner DL; Trenholme KR; Skinner-Adams TS; Teuscher F; Grembecka J; Mucha A; Kafarski P; Lua L; Bell A; Dalton JP
    J Biol Chem; 2007 Jan; 282(3):2069-80. PubMed ID: 17107951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The M17 leucine aminopeptidase of the malaria parasite Plasmodium falciparum: importance of active site metal ions in the binding of substrates and inhibitors.
    Maric S; Donnelly SM; Robinson MW; Skinner-Adams T; Trenholme KR; Gardiner DL; Dalton JP; Stack CM; Lowther J
    Biochemistry; 2009 Jun; 48(23):5435-9. PubMed ID: 19408962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.
    Skinner-Adams TS; Lowther J; Teuscher F; Stack CM; Grembecka J; Mucha A; Kafarski P; Trenholme KR; Dalton JP; Gardiner DL
    J Med Chem; 2007 Nov; 50(24):6024-31. PubMed ID: 17960925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin.
    Gardiner DL; Trenholme KR; Skinner-Adams TS; Stack CM; Dalton JP
    J Biol Chem; 2006 Jan; 281(3):1741-5. PubMed ID: 16286469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum.
    Teuscher F; Lowther J; Skinner-Adams TS; Spielmann T; Dixon MW; Stack CM; Donnelly S; Mucha A; Kafarski P; Vassiliou S; Gardiner DL; Dalton JP; Trenholme KR
    J Biol Chem; 2007 Oct; 282(42):30817-26. PubMed ID: 17720817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and cellular characterisation of the Plasmodium falciparum M1 alanyl aminopeptidase (PfM1AAP) and M17 leucyl aminopeptidase (PfM17LAP).
    Mathew R; Wunderlich J; Thivierge K; Cwiklinski K; Dumont C; Tilley L; Rohrbach P; Dalton JP
    Sci Rep; 2021 Feb; 11(1):2854. PubMed ID: 33536500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M17 leucine aminopeptidase of the human malaria parasite Plasmodium vivax.
    Lee JY; Song SM; Seok JW; Jha BK; Han ET; Song HO; Yu HS; Hong Y; Kong HH; Chung DI
    Mol Biochem Parasitol; 2010 Mar; 170(1):45-8. PubMed ID: 19931315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical target validation studies of aminopeptidase in malaria parasites using alpha-aminoalkylphosphonate and phosphonopeptide inhibitors.
    Cunningham E; Drag M; Kafarski P; Bell A
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3221-8. PubMed ID: 18458130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
    Chaudhary M; Singh V; Anvikar AR; Sahi S
    Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling of human leucyl aminopeptidases for in silico off target binding analysis of potential Plasmodium falciparum leucine aminopeptidase (PfA-M17) specific inhibitors.
    Sahi S; Raj U; Chaudhary M; Nain V
    Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(3):191-201. PubMed ID: 25269653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
    González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
    Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and chemical validation of
    Edgar RCS; Siddiqui G; Hjerrild K; Malcolm TR; Vinh NB; Webb CT; Holmes C; MacRaild CA; Chernih HC; Suen WW; Counihan NA; Creek DJ; Scammells PJ; McGowan S; de Koning-Ward TF
    Elife; 2022 Sep; 11():. PubMed ID: 36097817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin.
    Nankya-Kitaka MF; Curley GP; Gavigan CS; Bell A; Dalton JP
    Parasitol Res; 1998 Jul; 84(7):552-8. PubMed ID: 9694371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases.
    McGowan S; Oellig CA; Birru WA; Caradoc-Davies TT; Stack CM; Lowther J; Skinner-Adams T; Mucha A; Kafarski P; Grembecka J; Trenholme KR; Buckle AM; Gardiner DL; Dalton JP; Whisstock JC
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2449-54. PubMed ID: 20133789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active site metals mediate an oligomeric equilibrium in Plasmodium M17 aminopeptidases.
    Malcolm TR; Belousoff MJ; Venugopal H; Borg NA; Drinkwater N; Atkinson SC; McGowan S
    J Biol Chem; 2021; 296():100173. PubMed ID: 33303633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum.
    Dalal S; Klemba M
    J Biol Chem; 2007 Dec; 282(49):35978-87. PubMed ID: 17895246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases.
    Harbut MB; Velmourougane G; Dalal S; Reiss G; Whisstock JC; Onder O; Brisson D; McGowan S; Klemba M; Greenbaum DC
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E526-34. PubMed ID: 21844374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Hemoglobin Degrading Protease Falcipain-2 as a Mechanism for Anti-Malarial Activity of Triazole-Amino Acid Hybrids.
    Singh V; Hada RS; Uddin A; Aneja B; Abid M; Pandey KC; Singh S
    Curr Top Med Chem; 2020; 20(5):377-389. PubMed ID: 32000644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray crystal structure and specificity of the Plasmodium falciparum malaria aminopeptidase PfM18AAP.
    Sivaraman KK; Oellig CA; Huynh K; Atkinson SC; Poreba M; Perugini MA; Trenholme KR; Gardiner DL; Salvesen G; Drag M; Dalton JP; Whisstock JC; McGowan S
    J Mol Biol; 2012 Sep; 422(4):495-507. PubMed ID: 22709581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.